Journals / SSK Tepecik Eğitim Hastanesi Dergisi / 2004 / Cilt: 14 - Sayı: 3

Effects of steroid Withdrawal immunosuppressive protocols on graft function

Steroid kesilen immünsüpresif protokollerin transplante böbrek işlevlerine etkisi

Pages
183–188
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

To avoid the side effects of steroids in patients with stable graft functions, steroid wid0İOal immunosuppressive protocols can be preferred.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Steroid side effects have forced the clinicians to use steroid withdrawal immunosuppressive protocols after renal, transplantation.
📊
Key Findings & Data:We studied the effects of steroid withdrawal immunosuppressive protocols on graft function in this prospective study.Methods: 61 renal transplant patients who have had normal graft function for the last 6 months, and who have finished their second year after transplantation were randomized either to steroid withdrawal (n=31) or steroid continued (n=30) groups.
💡
Conclusion & Impact:To avoid the side effects of steroids in patients with stable graft functions, steroid wid0İOal immunosuppressive protocols can be preferred.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:İleriye dönük çalışma · Steroidler · Böbrek nakli

Abstract

Aim: Steroid side effects have forced the clinicians to use steroid withdrawal immunosuppressive protocols after renal, transplantation. We studied the effects of steroid withdrawal immunosuppressive protocols on graft function in this prospective study.Methods: 61 renal transplant patients who have had normal graft function for the last 6 months, and who have finished their second year after transplantation were randomized either to steroid withdrawal (n=31) or steroid continued (n=30) groups. The patients were followed up for 24 months. Patients within the groups were evaluated for their blood pressure (BP), number of acute rejection attack (ARA), fasting blood glucose, serum creatinine, trigliseride and cholestrol levels. Mean values of these parameters at 3,6,12 and 24 months were then compared with the basal mean values of the last six months before the beginning of study. For statistic alanalysis SPSS 11.0 program was used; p< 0.05 was accepted as significant. Results: In the steroid withdrawal group mean blood pressure, fasting glucose and creatinine levels were not statistically different than the pre-study basal values of the patients (p>0.05). Hence, trigliseride values were found statistically lower at each control; and cholestrol levels were also found lower at each control but statistical difference were found at the first three controls, within the two years (p<0.05). In the steroid-continued group non of the parameters showed statistical difference with the basal values (p<0.05). 3 attacks of acute rejections in the the steroid withdrawal group and 4 in the steroid continued group were seen (p=0.7). One chronic allograft nephropathy in the steroid withdrawal group and 3 in the steroid continued group were seen (p=0.19). In 12 patients in the steroid withdrawal group steroid was restarted after azathiopirin toxicity, acute rejection, chronic allograft nephropathy, elevated creatinine. Conclusion: Withdrawal of steroids, lowered serjum lipid levels although it did not affect fasting glucose level, arterial blood pressure, and acute'rejection rates. To avoid the side effects of steroids in patients with stable graft functions, steroid wid0İOal immunosuppressive protocols can be preferred.

Özet

Amaç: Son yıllarda, renal transplantasyon sonrası steroidlerin yan etkilerinden kaçınmak amacıyla steroidin kesildiği immünsüpresif protokollerin uygulanması yönündeki yaklaşımlar giderek artmıştır. Bu prospektif çalışmadaki amacımız steroidin kesildiği immünsüpresif protokollerin böbrek işlevleri ve kan lipid profili üzerindeki etkilerini araştırmaktır. Yöntem: Kliniğimizde böbrek nakli yapılan olgulardan, transplantasyon sonrası 2 yılını doldurmuş ve son 6 ay içinde böbrek işlevleri normal olan 18-57 yaş arası 61 olgu randomize edilerek steroid kesilen (n=31) ve kesilmeyen (n=30) olmak üzere iki grupta incelendi. İzlem süresi 24 ay idi. Gruplardaki olgular, açlık kan şekeri (AKŞ), kan basıncı (KB), akut rejeksiyon (AR) atağı sıklığı ve serum kreatinin, triglıserid, kolesterol düzeyleriyönünden değerlendirildi. İstatistiksel analizler SPSS 11.0 paket program kullanılarak yapıldı, p 0.05). Aynı guruptaki olgularda, trigliserdi düzeyleri 3,6,12 ve 24. ayların herbirinde bazal değerlere göre düşük bulunmuş ve istatistiksel fark yaratmıştır (p 0.05). Steroid kesilen gurupta izlem sürecinde 3, steroid kesilmeyen gurupta 4 olguda AR atağına rastlandı (p>0.05). Steroid kesilen gurupta 1, steroid kesilmeyen gurupta ise 3 hastada kronik allograft nefropatisi (KAN) görüldü (p>0.05). Steroid kesilen gurupta 12 olguda (2 azatioprin toksitesi, 3 AR, 1 KAN ve 6 hastada kreatinin yükselmesi nedeniyle) tekrar sterolde başlandı. Sonuç: Steroidlerin kesilmesi lipit değerlerini anlamlı olarak düşürmekte ancak AKŞ, KB ve AR oranlarını etkilememektedir. Bu nedenle böbrek işlevlerinin stabil seyrettiği olgularda steroidlerin olası yan etkilerinden korunmak amacıyla steroidin kesildiği immunsüpressif protokoller uygulanabilir kanısındayız.

🔖

Cite This Article

KARAOĞLAN, M., KAÇAR, S., GÜRKAN, A., VARILSÜHA, C., AKMAN, F., KARACA, C., BAŞAK, K. (2004). Effects of steroid Withdrawal immunosuppressive protocols on graft function. SSK Tepecik Eğitim Hastanesi Dergisi, Cilt: 14 - Sayı: 3, 183–188. https://ajindex.com/articles/312827

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Walker RG, d'Apis AJ. Azathioprine and Steroids in Kidney Transplantation; in Principles and Practice in Renal Transplantation. Ed. Morris PJ. WB Saunders Comp. Philadelphia, 1979 pp:319-339
  2. Veanstra DL, Best JH, Hornberger J, Sullivan SD, Hricik DE. Incidence and long-term cost of steroidrelated side effects after renal transplantation. Am J Kidney Dis 1999;33:829-839
  3. Ponticelli C. Steroid free immunosuppression. Transplant Proc 2001;33:3259-3260
  4. Hricik DE. Steroid withdrawal in renal transplant recipients: Pro point of view. Transplant Proc 1998; 30:1380-1382
  5. Birkeland SA. Steroid Ðfree immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy. Transplantation 1998;66: 1207-1210
  6. Birkeland SA. SteroidÐfree immunosuppression in renal transplantation. Transplantation 2001;71:1089- 1090
  7. Boots JM, Van Duijnhoven EM, Van Suylen RJ, Van Hooff JP. Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: A pilot study. Tansplantation 2002;74:1703-1709
  8. Matas AJ, Ramcharan T, Paraskevas S. Rapid discontinuation of steroids in living donor kidney transplantation: A pilot study. Am J Transplant 2001; 1:278-283
  9. Maes BD, Claes K, Coosemans W. Cessation of steroids in stable renal transplant patients: the Leuven experience. Clin Transpl 2002;17:181-189
  10. Yagisawa T, Nakada T, Hiromasa Y. Successful steroid withdrawal half a year after kidney transplantation. Int Urol Nephrol 1995;27:495-501
  11. Cole E, Landsberg D, Russel D. A pilot study of steroidÐ free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation 2001;72:845-850
  12. Kuypers DR, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanren Y. The use of anti-CD monoclonal antibody and mycopheolate mofetil enables the use of a low-dose tacrolimus and early withdrawal of steroids in renal transplant recipients. Clin Transplant 2003;17:234-241
  13. Vincenti F, Monaco A, Grinyo J, Kinkhabwala M. Roza A. Multicenter randomized prospective transplant recipients receiving basiliximab, cyclosporin microemulsion and mycophenolate mofetil. Am J Transplant 2003;3:306-311
  14. Rootnat JI, Mulder PGH, Zietze R. Cholesterol as an independent predictor of outcome after renal transplantation. Transplantation 2000;69:1704-1710
  15. Mital D, Podlasek W, Jensik SC. Sirolimus based steroid free immunosuppression. Transplant Proc 2002; 34: 17